PTIE

5 Long, 2 Shorts for February 16, 2010	11 Stocks to Trade the Week of February 22, 2010	Dan Loeb's Third Point Likes Citigroup and Transdigm Group
Pfizer's Osteoarthritis Drug Runs Into Unique Roadblock	Pfizer Is Not Paying a Ransom for King	Pain Therapeutics: Optimistic Indicators, Large Upside Potential
Pain Therapeutics: Optimistic Indicators, Large Upside Potential	Pharmaceutical Companies Reformulate Pain Products: How Investors Can Benefit	Pain Therapeutics' Opium for the Masses
25 Small Caps With Sales and EPS Declining in 2012	Previewing a Pair of Pain Drug FDA Decisions	Platform and Specialty Pharmaceutical Companies Could Strengthen in Face of Big Pharma's Patent Cliff
12 Healthcare Companies Looking at June Catalysts	Friday Options Recap	4 Pharma Stocks That Should See a Surge in Interest Next Week
The FDA's Drug Approval Agenda for Next Week	Building a Biotech Portfolio With High Potential Returns, Modest Risk	4 Stocks That Saw Extreme Selling Pressure on Friday
Busy Week for FDA Leads to Volatile Action in 5 Pharma Stocks	Healthcare Stocks in Focus on Monday	Stocks Seeing Selling Pressure This Week
4 Big Losers From Last Week	Pfizer Guidance Suggests Tremendous Potential for Pain Therapeutics	Pain Management Stocks: Will This Painful Downturn End Soon?

Main menu